"10.1371_journal.pone.0028527","plos one","2011-12-21T00:00:00Z","Madhav Thambisetty; Andrew Simmons; Abdul Hye; James Campbell; Eric Westman; Yi Zhang; Lars-Olof Wahlund; Anna Kinsey; Mirsada Causevic; Richard Killick; Iwona Kloszewska; Patrizia Mecocci; Hilkka Soininen; Magda Tsolaki; Bruno Vellas; Christian Spenger; Simon Lovestone; for the AddNeuroMed consortium","Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, United States of America; Kings College London, Institute of Psychiatry, London, United Kingdom; Proteome Sciences plc, Coveham House, Cobham, United Kingdom; Department of Clinical Science, Intervention and Technology, Division of Radiology, Karolinska Institutet, Stockholm, Sweden; Department of Neurobiology, Care Sciences and Society, Section of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden; Department of Old Age Psychiatry and Psychotic Disorders, Medical University of Lodz, Lodz, Poland; Section of Gerontology and Geriatrics, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy; Department of Neurology, University of Eastern Finland and University Hospital, Kuopio, Finland; Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece; Department of Internal and Geriatrics Medicine, HÃ´pitaux de Toulouse, Toulouse, France","Conceived and designed the experiments: Madhav Thambisetty AS SL. Performed the experiments: Madhav Thambisetty AS AH AK MC RK. Analyzed the data: AS Madhav Thambisetty EW JC YZ. Contributed reagents/materials/analysis tools: L-OW IK PM HS Magda Tsolaki BV CS SL. Wrote the paper: Madhav Thambisetty AS SL.","As detailed below, intellectual property has been registered on the use of plasma proteins for use as biomarkers for AD by Kings College London and Proteome Sciences, with Drs. Lovestone, Campbell, and Thambisetty named as inventors. Dr. Campbell was a full-time employee of Proteome Sciences, London, U.K., at the time of his contribution to the work described in this manuscript. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials. Patent Title Methods and Compositions Relating to Alzheimers Disease Subject Covers utility of around 30 proteins, specifically listing 16 in the Dependent claims for diagnosis of Alzheimers disease Filing Proteome Sciences with Kings Business UK Priority GB0421639.6 dated 29/09/2004 PCT Application PCT/GB2005/003756 dated 29/09/2005 Application in Europe, Japan, US, Australia, and Canada, dated 15/03/2007 to 16/10/2007.","2011","12","Madhav Thambisetty","MT",18,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
